22 May 2013
Keywords: reassuring, cv, safety, ph, iiib, cycloset, trial
Article | 02 July 2007
VeroScience, a privately-held biotechnology firm, and its partner, fellow USA-based S2 Therapeutics, have reported results from a Phase
IIIb clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 July 2007
21 May 2013
© 2013 thepharmaletter.com